tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market

Immunovant (IMVT) Technical Analysis

Compare
836 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Immunovant’s (IMVT) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Immunovant is a Sell.
Immunovant’s (IMVT) 20-Day exponential moving average is 14.94, while Immunovant’s (IMVT) share price is $16.02, making it a Buy.
Immunovant’s (IMVT) 50-Day exponential moving average is 15.72, while Immunovant’s (IMVT) share price is $16.02, making it a Buy.

Immunovant (IMVT) Pivot Points

Jun 07, 2025, 02:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.85
15.07
15.21
15.43
15.57
15.79
15.93
Fibonacci
15.07
15.21
15.30
15.43
15.57
15.66
15.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunovant (IMVT) Moving Averages

Jun 07, 2025, 02:22 AM
Period
Simple
Exponential
MA5
15.41Buy
15.45Buy
MA10
14.94Buy
15.13Buy
MA20
14.63Buy
14.94Buy
MA50
15.08Buy
15.72Buy
MA100
17.91Sell
17.94Sell
MA200
23.31Sell
22.03Sell
Immunovant’s (IMVT) 10-Day exponential moving average is 15.13, while Immunovant’s (IMVT) share price is $16.02, making it a Buy.
Immunovant’s (IMVT) 100-Day exponential moving average is 17.94, while Immunovant’s (IMVT) share price is $16.02, making it a Sell.
Immunovant’s (IMVT) stock price is $16.02 and Immunovant’s (IMVT) 50-day simple moving average is 15.08, creating a Buy signal.
Immunovant’s (IMVT) stock price is $16.02 and Immunovant’s (IMVT) 100-day simple moving average is 17.91, creating a Sell signal.
Immunovant’s (IMVT) stock price is $16.02 and Immunovant’s (IMVT) 200-day simple moving average is 23.31, creating a Sell signal.

Immunovant (IMVT) Technical Indicators

Jun 07, 2025, 02:22 AM
Name
Value
Implied Action
RSI (14)
60.46
Neutral
STOCH (9,6)
83.40
Sell
STOCHRSI (14)
84.81
Sell
MACD (12,26)
0.07
Sell
ADX (14)
21.18
Neutral
Williams %R
-5.71
Sell
CCI (14)
185.77
Sell
ATR (14)
0.84
-
Ultimate Oscillator
61.03
Neutral
ROC
15.09
Buy
Immunovant’s (IMVT) Relative Strength Index (RSI) is 60.46, creating a Neutral signal.
Immunovant’s (IMVT) Trend Strength Indicator (ADX) is 21.18, creating a Neutral signal.
Immunovant’s (IMVT) Commodity Channel Index (CCI) is 185.77, creating a Sell signal.
Immunovant’s (IMVT) Price Rate of Change (ROC) is 15.09, creating a Buy signal.

FAQ

Is IMVT a Buy, Hold, or Sell?
Based on IMVT’s technical indicators, IMVT is a Hold.
    What is IMVT’s RSI (14)?
    IMVT’s RSI (14) is 60.46, which suggests IMVT is a Neutral.
      What is IMVT’s MACD?
      IMVT’s MACD is 0.07, which suggests IMVT is a Sell.
        What is IMVT’s 5-day moving average?
        IMVT’s 5-day moving average is 15.41, which suggests IMVT is a Buy.
          What is IMVT’s 20-day moving average?
          IMVT 20-day moving average is 14.63, which suggests IMVT is a Buy.
            What is IMVT’s 50-day moving average?
            IMVT’s 50-day moving average is 15.08, which suggests IMVT is a Buy.
              What is IMVT’s 200-day moving average?
              IMVT’s 200-day moving average is 23.31, which suggests IMVT is a Sell.
                What is IMVT’s Williams % R (14)?
                IMVT’s Williams % R (14) is -5.71, which suggests IMVT is a Sell.
                  What is IMVT’s CCI (14)?
                  IMVT’s CCI (14) is 185.77, which suggests IMVT is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis